We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+9.76%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.3B
AUM Growth
+$92.1M
Cap. Flow
+$25M
Cap. Flow %
1.92%
Top 10 Hldgs %
36.27%
Holding
543
New
63
Increased
193
Reduced
214
Closed
47

Top Buys

Rank Stock Value
1
UGL icon
ProShares Ultra Gold
UGL
+$16.2M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.26M
3
MU icon
Micron Technology
MU
+$4.07M
4
META icon
Meta Platforms (Facebook)
META
+$3.94M
5
RACE icon
Ferrari
RACE
+$2.98M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$11.5M
2
SLV icon
iShares Silver Trust
SLV
+$7.75M
3
AMZN icon
Amazon
AMZN
+$6.78M
4
ORCL icon
Oracle
ORCL
+$2.75M
5
RCL icon
Royal Caribbean
RCL
+$2.72M

Sector Composition

Rank Sector Weight
1 Technology 37.86%
2 Healthcare 22.63%
3 Communication Services 13.04%
4 Consumer Discretionary 10.29%
5 Consumer Staples 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELVN icon
376
Enliven Therapeutics
ELVN
$4.24B
$149K 0.01%
9,671
-712
-7% -$14.2K
GOSS icon
377
Gossamer Bio
GOSS
$86.8M
$148K 0.01%
+47,716
New +$136K
KURA icon
378
Kura Oncology
KURA
$882M
$147K 0.01%
14,179
-1,035
-7% -$10.9K
MESO
379
Mesoblast
MESO
$2.18B
$144K 0.01%
7,992
-284
-3% -$4.89K
ESPR
380
DELISTED
Esperion Therapeutics
ESPR
$144K 0.01%
38,955
+3,614
+10% +$11.7K
CRVS icon
381
Corvus Pharmaceuticals
CRVS
$1.27B
$140K 0.01%
18,169
+5,108
+39% +$40.3K
GERN icon
382
Geron
GERN
$1.01B
$137K 0.01%
104,020
-7,815
-7% -$9.8K
VIR icon
383
Vir Biotechnology
VIR
$1.52B
$137K 0.01%
22,670
-1,680
-7% -$10K
ON icon
384
ON Semiconductor
ON
$32.4B
$135K 0.01%
2,500
-10,797
-81% -$554K
AVBP icon
385
ArriVent BioPharma
AVBP
$1.47B
$135K 0.01%
6,727
-384
-5% -$7.99K
JANX icon
386
Janux Therapeutics
JANX
$1.02B
$135K 0.01%
9,801
-733
-7% -$17.2K
KALV
387
DELISTED
KalVista Pharmaceuticals
KALV
$133K 0.01%
8,236
-588
-7% -$7.79K
ORIC icon
388
Oric Pharmaceuticals
ORIC
$1.43B
$130K 0.01%
15,870
-11,154
-41% -$128K
AQST icon
389
Aquestive Therapeutics
AQST
$531M
$128K 0.01%
19,880
-1,325
-6% -$8.26K
GHRS icon
390
GH Research
GHRS
$2.08B
$128K 0.01%
+10,107
New +$138K
RIGL icon
391
Rigel Pharmaceuticals
RIGL
$782M
$127K 0.01%
2,958
-186
-6% -$7.01K
TECX
392
Tectonic Therapeutic
TECX
$720M
$126K 0.01%
6,050
-830
-12% -$15.4K
PAHC icon
393
Phibro Animal Health
PAHC
$1.37B
$124K 0.01%
3,332
-238
-7% -$9.67K
REPL icon
394
Replimune Group
REPL
$1.28B
$124K 0.01%
12,782
-900
-7% -$7.65K
ARVN icon
395
Arvinas
ARVN
$580M
$124K 0.01%
10,465
-2,404
-19% -$26.2K
TMDX icon
396
Transmedics
TMDX
$3.02B
$122K 0.01%
1,000
– –
ABSI icon
397
Absci
ABSI
$1.61B
$120K 0.01%
34,503
+8,294
+32% +$30.2K
RGNX icon
398
Regenxbio
RGNX
$720M
$119K 0.01%
8,249
-605
-7% -$7.54K
LXEO icon
399
Lexeo Therapeutics
LXEO
$382M
$118K 0.01%
11,893
+2,427
+26% +$22.1K
CTMX icon
400
CytomX Therapeutics
CTMX
$760M
$118K 0.01%
+27,609
New +$105K
14 15
16
17 18

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2025 Portfolio in Review

As of Q4 2025, China Universal Asset Management Company held 543 positions worth $1.3B, up 7.6% from $1.21B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

China Universal Asset Management Company's Q4 2025 filing shows 63 new, 193 increased, 214 reduced and 47 closed positions. Its largest new stake was Western Digital: 13,175 shares worth $2.27M. The largest sale was Broadcom, an estimated $11.5M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 40% a quarter earlier, followed by Healthcare and Communication Services.

  • China Universal Asset Management Company's largest Q4 2025 buy was Western Digital: 13,175 shares worth $2.27M.
  • China Universal Asset Management Company added most to ProShares Ultra Gold in Q4 2025, an estimated $16.2M increase.
  • China Universal Asset Management Company's biggest Q4 2025 reduction was Broadcom, cutting an estimated $11.5M.
  • China Universal Asset Management Company fully exited Royal Caribbean in Q4 2025, selling an estimated $2.72M.
  • China Universal Asset Management Company's ten largest holdings make up 36% of its $1.3B portfolio in Q4 2025.
  • China Universal Asset Management Company opened 63 new positions and closed 47 in Q4 2025.
  • China Universal Asset Management Company's portfolio value rose 7.6% quarter-over-quarter to $1.3B.

Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.